News & Articles

Obtaining two vaccine doses remains the most effective way to ensure protection against the COVID-19 Delta variant

Fewer than one in 20 children with symptomatic COVID-19 experienced symptoms lasting longer than 4 weeks, and almost all children have fully recovered by 8 weeks

Patients with underlying heart problems are more than four times as likely to die from COVID-19

Low-cost device lets consumers check themselves for multiple strains of SARS-CoV-2 at home

Researchers have cataloged for the first time

It is hoped this therapy will be a breakthrough for patients suffering from hereditary transthyretin (ATTR) amyloidosis

Ultra-high precision off-axis paraboloids are being used to maximize power density at the focus of Petawatt laser beamlines

The Amulet is the first and only minimally invasive treatment option to offer immediate closure of the left atrial appendage, so blood-thinning medication isn't needed following implantation

The company plans to interface the algorithm into the Atellica Data Manager software in the future

Wastewater surveillance is becoming increasingly critical for community health monitoring for detecting COVID-19 outbreaks and the spread of other infectious diseases

Population genetics sequencing panel incorporates global genetic variations for superior study of disease and target discovery

The new intuitive interface provides step-by-step guidance to enhance ease of use

INTEGRA Biosciences has created a list of key steps to control laboratory resource consumption and waste production in an attempt to reduce environmental footprint

Nobelpharma will use ProBioGen’s cell-based production platform AGE1.CR.pIX to develop their lead vaccine

Project supports Croda’s global Research & Development Digital Program across all R&D locations

Molecular Cartography platform features leading microscopy and 3D imaging capabilities

Vaccine aims to combat numerous HIV strains, a key requirement of any vaccine to end the HIV/AIDs epidemic

Johan Engström, Senior Scientist at Gyros Protein Technologies, discusses the challenges of measuring high-affinity interactions of ligands in cancer immunotherapy